Skip to main content
EJNMMI Research

Table 2 PSMA expression according to the ATA risk of structural disease recurrence (n = 23)

From: The complementary role of PSMA expression and [18F]FDG PET/CT in predicting thyroid cancer outcome: from black and white to shades of gray, in the era of precision oncology

ATA risk of structural disease recurrence

PSMA expression

Negative (n = 6)

Positive (n = 17)

Low risk

0

2

Intermediate risk

4

2

High risk

2

9

Not assessable (poorly differentiated)

0

4

Back to article page